drugset
drugset / Trial / NCT01131000

Efficacy, Safety, and Pharmacokinetics of Intravenous Ibuprofen in Adult Febrile Patients

NCT01131000 ↗

Phase 3 Completed 123 enrolled Cumberland Pharmaceuticals
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary objective of this study is to evaluate the efficacy of intravenous ibuprofen on reducing fever at 4 hours.

Timeline

Start
2002-06
Primary completion
2005-08
Completion
2005-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule 100 mg Intravenous
Subject Ibuprofen Small molecule 200 mg Intravenous
Subject Ibuprofen Small molecule 400 mg Intravenous

Indications

No indication recorded.